In a new study led by @roelverhaak.bsky.social, it was revealed that two types of #gliomas—astrocytomas and oligodendrogliomas—develop radically different mutations as they become more treatment resistant. medicine.yale.edu/cancer/news-... @nature.com

Show Post

Our next chapter in the book of GLASS now online. IDH-mutant gliomas are interesting from a cancer evolution perspective due to the heterogeneous treatment and (relatively) long time to recurrence, providing an opportunity to study treatment-related adaptations. www.nature.com/articles/s41...

Show Post

Congratulations to Michael Weller on receiving the prestigious #EANO Leadership Award 2026 at #EANO2026 in #Rome! This award recognises his outstanding contributions to #NeuroOncology and his long-standing commitment to EANO. Thank you for helping shape EANO and the field of neuro-oncology!

Show Post

👏 International academic collaboration delivering answers. Just presented at #EANO2026, the ROAM/EORTC-1308 phase III trial found that radiotherapy significantly reduces recurrence risk after complete resection of atypical meningioma. 🔗 www.eortc.org/blog/2026/09... @eanoassociation.bsky.social

Show Post

@leilaakkari.bsky.social @imkeller.bsky.social @drmistyjenkins.bsky.social @yahayayabo.bsky.social

Show Post